OTCQB

7 articles
BenzingaBenzinga··Prnewswire

Syra Health Set to Report Q1 2026 Results, Signaling Growth in Digital Health Sector

Syra Health to report Q1 2026 results May 7, providing key insights into digital health and prevention-focused healthcare platform performance.
SYRAfinancial resultsOTCQB
BenzingaBenzinga··Prnewswire

NIDB Maintains Dividend Commitment With $0.19 Payout Amid Steady Leadership

NIDB announces $0.19 dividend yielding 3.37%, elects directors at 31st shareholder meeting. Stock trading at $22.52.
NIDBcash dividenddividend yield
BenzingaBenzinga··Prnewswire

URSB Bancorp Completes IPO After Mutual-to-Stock Conversion, Raises $23.1M

URSB Bancorp closes IPO after mutual-to-stock conversion, raising $23.1M at $10 per share. $URSB begins trading March 27, 2026.
URSBstock offeringIPO
BenzingaBenzinga··Prnewswire

RMX Industries Appoints VStock Transfer as New Transfer Agent

RMX Industries appoints VStock Transfer as new transfer agent, enhancing shareholder services and administrative infrastructure for the OTCQB-listed technology company.
RMXIOTCQBtransfer agent
BenzingaBenzinga··Prnewswire

RMX Industries Files Confidential S-1 Ahead of Potential Public Offering

RMX Industries confidentially files S-1 registration with SEC for potential public offering of Class A stock by existing shareholders, signaling move toward broader market accessibility.
RMXISEC filingClass A Common Stock
BenzingaBenzinga··Prnewswire

Syra Health to Unveil 2025 Full-Year Results as Company Eyes Growth Trajectory

Syra Health ($SYRA) will report fourth-quarter and full-year 2025 financial results on March 12, 2026, before market open.
SYRAfinancial resultsearnings announcement
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Creatd Executes Reverse Split to Meet Exchange Listing Standards

Creatd completed a 1-for-20 reverse stock split on February 24 to meet exchange listing requirements and minimum bid price thresholds. No financing activities accompany the technical restructuring.
CRTDreverse stock splitshareholder approval